IPAD-DB ID | C00717 |
Name | α-Santalol |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 2 4 O |
Molecular Weight | 220.35 g/mol |
IUPAC Name | (Z)-5-[(1R, 3R, 6S)-2, 3-dimethyl-3-tricyclo[2.2.1.02, 6]heptanyl]-2-methylpent-2-en-1-ol |
InChI | InChI=1S/C15H24O/c1-10(9-16)5-4-6-14(2)11-7-12-13(8-11)15(12, 14)3/h5, 11-13, 16H, 4, 6-9H2, 1-3H3/b10-5-/t11?, 12-, 13+, 14-, 15?/m1/s1 |
InChIKey | PDEQKAVEYSOLJX-RQGDDBKYSA-N |
Canonical SMILES | CC(=CCCC1(C2CC3C1(C3C2)C)C)CO |
PubChem CID | 11085337 |
DrugBank Accession Number | - |
CAS Registry Number | 115-71-9 |
Molecular Weight(Computed by SwissADME) | 220.35 |
Hac(Computed by SwissADME) | 16 |
Volume(Computed by ADMETlab 2.0) | 248.481 |
Density(Computed by ADMETlab 2.0) | 0.886 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 0 |
nHet(Computed by ADMETlab 2.0) | 1 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 10 |
Flexibility(Computed by ADMETlab 2.0) | 0.4 |
Stero Centers(Computed by ADMETlab 2.0) | 3 |
LogS(Computed by ADMETlab 2.0) | -4.228 |
LogD(Computed by ADMETlab 2.0) | 3.752 |
logP(Computed by ADMETlab 2.0) | 3.992 |
TPSA(Computed by SwissADME) | 20.23 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -4.83 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 1 |
Bioavailability Score(Computed by SwissADME) | 0.55 |